comparemela.com

Page 13 - Lon Gsk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Insider Buying: GSK plc (LON:GSK) Insider Buys £29,379 in Stock

GSK plc (LON:GSK – Get Rating) insider Jonathan Symonds acquired 2,100 shares of the business’s stock in a transaction dated Monday, March 20th. The stock was purchased at an average price of GBX 1,399 ($17.18) per share, with a total value of £29,379 ($36,078.84). GSK Stock Down 0.0 % Shares of LON:GSK opened at GBX […]

Deutsche Bank Aktiengesellschaft Analysts Give GSK (LON:GSK) a GBX 1,700 Price Target

Deutsche Bank Aktiengesellschaft set a GBX 1,700 ($20.88) price target on GSK (LON:GSK – Get Rating) in a research note released on Monday, Borsen Zeitung reports. GSK has been the topic of a number of other reports. Jefferies Financial Group set a GBX 1,575 ($19.34) price objective on GSK in a report on Wednesday, February […]

GlaxoSmithKline (LON:GSK) Stock Rating Reaffirmed by Deutsche Bank Aktiengesellschaft

GlaxoSmithKline (LON:GSK – Get Rating)‘s stock had its “hold” rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft in a report issued on Tuesday, Marketbeat reports. They presently have a GBX 1,750 ($21.24) target price on the stock. Deutsche Bank Aktiengesellschaft’s price target would indicate a potential upside of 2.48% from the company’s current price. GSK […]

GlaxoSmithKline s (GSK) Equal Weight Rating Reiterated at Barclays

GlaxoSmithKline (LON:GSK – Get Rating)‘s stock had its “equal weight” rating reiterated by Barclays in a research note issued on Monday, Marketbeat.com reports. They presently have a GBX 1,800 ($22.65) target price on the stock. Barclays‘s target price would suggest a potential upside of 4.72% from the stock’s current price. Several other equities analysts have […]

GlaxoSmithKline (LON:GSK) Given a GBX 1,800 Price Target at Barclays

Barclays set a GBX 1,800 ($22.94) target price on GlaxoSmithKline (LON:GSK – Get Rating) in a research report released on Friday, Borsen Zeitung reports. A number of other research firms also recently commented on GSK. The Goldman Sachs Group set a GBX 2,000 ($25.49) target price on GlaxoSmithKline in a research report on Friday, January […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.